Summary
According to APO Research, The global Famciclovir market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Famciclovir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Famciclovir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Famciclovir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Famciclovir is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Famciclovir include Teva, Shandong Luoxin Pharmaceutical Group, Novartis, Mylan, Hainan choitec Pharmaceuticals, Chengdu Diao Pharmaceutical Group, Beijing Jialin Pharmaceutical, Macleods Pharmaceuticals and HISUN, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Famciclovir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Famciclovir, also provides the sales of main regions and countries. Of the upcoming market potential for Famciclovir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Famciclovir sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Famciclovir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Famciclovir sales, projected growth trends, production technology, application and end-user industry.
Famciclovir Segment by Company
Teva
Shandong Luoxin Pharmaceutical Group
Novartis
Mylan
Hainan choitec Pharmaceuticals
Chengdu Diao Pharmaceutical Group
Beijing Jialin Pharmaceutical
Macleods Pharmaceuticals
HISUN
Hikma
HETERO
Cipla
Aurobindo Pharma
Apotex
Famciclovir Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Famciclovir Segment by Application
Cold Sores
Shingles
Genital Herpes
Famciclovir Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Famciclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Famciclovir market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Famciclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
- Market Overview
- Product Definition
- Global Famciclovir Market Size, 2020 VS 2024 VS 2031
- Global Famciclovir Market Size Estimates and Forecasts (2020-2031)
- Global Famciclovir Sales Estimates and Forecasts (2020-2031)
- Global Famciclovir Market Average Price (2020-2031)
- Assumptions and Limitations
- Study Goals and Objectives
- Global Famciclovir Market Dynamics
- Famciclovir Industry Trends
- Famciclovir Industry Drivers
- Famciclovir Industry Opportunities and Challenges
- Famciclovir Industry Restraints
- Famciclovir Market by Manufacturers
- Global Famciclovir Revenue by Manufacturers (2020-2025)
- Global Famciclovir Sales by Manufacturers (2020-2025)
- Global Famciclovir Average Sales Price by Manufacturers (2020-2025)
- Global Famciclovir Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- Global Famciclovir Key Manufacturers Manufacturing Sites & Headquarters
- Global Famciclovir Manufacturers, Product Type & Application
- Global Famciclovir Manufacturers Establishment Date
- Market Competitive Analysis
- Global Famciclovir Market CR5 and HHI
- Global Top 5 and 10 Famciclovir Players Market Share by Revenue in 2024
- 2024 Famciclovir Tier 1, Tier 2, and Tier 3
- Famciclovir Market by Type
- Famciclovir Type Introduction
- 125 mg Tablets
- 250 mg Tablets
- 500 mg Tablets
- Global Famciclovir Sales by Type
- Global Famciclovir Sales by Type (2020 VS 2024 VS 2031)
- Global Famciclovir Sales by Type (2020-2031)
- Global Famciclovir Sales Market Share by Type (2020-2031)
- Global Famciclovir Revenue by Type
- Global Famciclovir Revenue by Type (2020 VS 2024 VS 2031)
- Global Famciclovir Revenue by Type (2020-2031)
- Global Famciclovir Revenue Market Share by Type (2020-2031)
- Famciclovir Type Introduction
- Famciclovir Market by Application
- Famciclovir Application Introduction
- Cold Sores
- Shingles
- Genital Herpes
- Global Famciclovir Sales by Application
- Global Famciclovir Sales by Application (2020 VS 2024 VS 2031)
- Global Famciclovir Sales by Application (2020-2031)
- Global Famciclovir Sales Market Share by Application (2020-2031)
- Global Famciclovir Revenue by Application
- Global Famciclovir Revenue by Application (2020 VS 2024 VS 2031)
- Global Famciclovir Revenue by Application (2020-2031)
- Global Famciclovir Revenue Market Share by Application (2020-2031)
- Famciclovir Application Introduction
- Global Famciclovir Sales by Region
- Global Famciclovir Sales by Region: 2020 VS 2024 VS 2031
- Global Famciclovir Sales by Region (2020-2031)
- Global Famciclovir Sales by Region (2020-2025)
- Global Famciclovir Sales Forecasted by Region (2025-2030)
- North America
- North America Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- North America Famciclovir Sales by Country (2020-2031)
- U.S.
- Canada
- Mexico
- Europe
- Europe Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- Europe Famciclovir Sales by Country (2020-2031)
- Germany
- France
- U.K.
- Italy
- Netherlands
- Asia Pacific
- Asia Pacific Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- Asia Pacific Famciclovir Sales by Country (2020-2031)
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- South America, Middle East and Africa
- South America, Middle East and Africa Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- South America, Middle East and Africa Famciclovir Sales by Country (2020-2031)
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- Argentina
- UAE
- Egypt
- Chile
- Global Famciclovir Revenue by Region
- Global Famciclovir Revenue by Region
- Global Famciclovir Revenue by Region: 2020 VS 2024 VS 2031
- Global Famciclovir Revenue by Region (2020-2025)
- Global Famciclovir Revenue by Region (2026-2031)
- Global Famciclovir Revenue Market Share by Region (2020-2031)
- North America
- North America Famciclovir Revenue (2020-2031)
- North America Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031
- Europe
- Europe Famciclovir Revenue (2020-2031)
- Europe Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031
- Asia-Pacific
- Asia-Pacific Famciclovir Revenue (2020-2031)
- Asia-Pacific Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031
- South America, Middle East and Africa
- South America, Middle East and Africa Famciclovir Revenue (2020-2031)
- South America, Middle East and Africa Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031
- Global Famciclovir Revenue by Region
- Company Profiles
- Teva
- Teva Comapny Information
- Teva Business Overview
- Teva Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Teva Famciclovir Product Portfolio
- Teva Recent Developments
- Shandong Luoxin Pharmaceutical Group
- Shandong Luoxin Pharmaceutical Group Comapny Information
- Shandong Luoxin Pharmaceutical Group Business Overview
- Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
- Shandong Luoxin Pharmaceutical Group Recent Developments
- Novartis
- Novartis Comapny Information
- Novartis Business Overview
- Novartis Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Novartis Famciclovir Product Portfolio
- Novartis Recent Developments
- Mylan
- Mylan Comapny Information
- Mylan Business Overview
- Mylan Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Mylan Famciclovir Product Portfolio
- Mylan Recent Developments
- Hainan choitec Pharmaceuticals
- Hainan choitec Pharmaceuticals Comapny Information
- Hainan choitec Pharmaceuticals Business Overview
- Hainan choitec Pharmaceuticals Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
- Hainan choitec Pharmaceuticals Recent Developments
- Chengdu Diao Pharmaceutical Group
- Chengdu Diao Pharmaceutical Group Comapny Information
- Chengdu Diao Pharmaceutical Group Business Overview
- Chengdu Diao Pharmaceutical Group Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
- Chengdu Diao Pharmaceutical Group Recent Developments
- Beijing Jialin Pharmaceutical
- Beijing Jialin Pharmaceutical Comapny Information
- Beijing Jialin Pharmaceutical Business Overview
- Beijing Jialin Pharmaceutical Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
- Beijing Jialin Pharmaceutical Recent Developments
- Macleods Pharmaceuticals
- Macleods Pharmaceuticals Comapny Information
- Macleods Pharmaceuticals Business Overview
- Macleods Pharmaceuticals Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Macleods Pharmaceuticals Famciclovir Product Portfolio
- Macleods Pharmaceuticals Recent Developments
- HISUN
- HISUN Comapny Information
- HISUN Business Overview
- HISUN Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- HISUN Famciclovir Product Portfolio
- HISUN Recent Developments
- Hikma
- Hikma Comapny Information
- Hikma Business Overview
- Hikma Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Hikma Famciclovir Product Portfolio
- Hikma Recent Developments
- HETERO
- HETERO Comapny Information
- HETERO Business Overview
- HETERO Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- HETERO Famciclovir Product Portfolio
- HETERO Recent Developments
- Cipla
- Cipla Comapny Information
- Cipla Business Overview
- Cipla Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Cipla Famciclovir Product Portfolio
- Cipla Recent Developments
- Aurobindo Pharma
- Aurobindo Pharma Comapny Information
- Aurobindo Pharma Business Overview
- Aurobindo Pharma Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Aurobindo Pharma Famciclovir Product Portfolio
- Aurobindo Pharma Recent Developments
- Apotex
- Apotex Comapny Information
- Apotex Business Overview
- Apotex Famciclovir Sales, Price, Revenue and Gross Margin (2020-2025)
- Apotex Famciclovir Product Portfolio
- Apotex Recent Developments
- Teva
- Value Chain and Sales Channels Analysis
- Famciclovir Value Chain Analysis
- Famciclovir Key Raw Materials
- Raw Materials Key Suppliers
- Manufacturing Cost Structure
- Famciclovir Production Mode & Process
- Famciclovir Sales Channels Analysis
- Direct Comparison with Distribution Share
- Famciclovir Distributors
- Famciclovir Customers
- Famciclovir Value Chain Analysis
- Concluding Insights
- Appendix
- Reasons for Doing This Study
- Research Methodology
- Research Process
- Authors List of This Report
- Data Source
- Secondary Sources
- Primary Sources
- Disclaimer
List of Tables
Table 1 | :Famciclovir Industry Trends |
Table 2 | :Famciclovir Industry Drivers |
Table 3 | :Famciclovir Industry Opportunities and Challenges |
Table 4 | :Famciclovir Industry Restraints |
Table 5 | :Global Famciclovir Revenue by Manufacturers (US$ Million) & (2020-2025) |
Table 6 | :Global Famciclovir Revenue Market Share by Manufacturers (2020-2025) |
Table 7 | :Global Famciclovir Sales by Manufacturers (W Units) & (2020-2025) |
Table 8 | :Global Famciclovir Sales Market Share by Manufacturers |
Table 9 | :Global Famciclovir Average Sales Price (US$/Unit) of Manufacturers (2020-2025) |
Table 10 | :Global Famciclovir Industry Manufacturers Ranking, 2023 VS 2024 VS 2025 |
Table 11 | :Global Famciclovir Key Manufacturers Manufacturing Sites & Headquarters |
Table 12 | :Global Famciclovir Manufacturers, Product Type & Application |
Table 13 | :Global Famciclovir Manufacturers Establishment Date |
Table 14 | :Global Manufacturers Market Concentration Ratio (CR5 and HHI) |
Table 15 | :Global Famciclovir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2024) |
Table 16 | :Major Manufacturers of 125 mg Tablets |
Table 17 | :Major Manufacturers of 250 mg Tablets |
Table 18 | :Major Manufacturers of 500 mg Tablets |
Table 19 | :Global Famciclovir Sales by Type 2020 VS 2024 VS 2031 (W Units) |
Table 20 | :Global Famciclovir Sales by Type (2020-2025) & (W Units) |
Table 21 | :Global Famciclovir Sales by Type (2026-2031) & (W Units) |
Table 22 | :Global Famciclovir Sales Market Share by Type (2020-2025) |
Table 23 | :Global Famciclovir Sales Market Share by Type (2026-2031) |
Table 24 | :Global Famciclovir Revenue by Type 2020 VS 2024 VS 2031 (W Units) |
Table 25 | :Global Famciclovir Revenue by Type (2020-2025) & (W Units) |
Table 26 | :Global Famciclovir Revenue by Type (2026-2031) & (W Units) |
Table 27 | :Global Famciclovir Revenue Market Share by Type (2020-2025) |
Table 28 | :Global Famciclovir Revenue Market Share by Type (2026-2031) |
Table 29 | :Major Manufacturers of Cold Sores |
Table 30 | :Major Manufacturers of Shingles |
Table 31 | :Major Manufacturers of Genital Herpes |
Table 32 | :Global Famciclovir Sales by Application 2020 VS 2024 VS 2031 (W Units) |
Table 33 | :Global Famciclovir Sales by Application (2020-2025) & (W Units) |
Table 34 | :Global Famciclovir Sales by Application (2026-2031) & (W Units) |
Table 35 | :Global Famciclovir Sales Market Share by Application (2020-2025) |
Table 36 | :Global Famciclovir Sales Market Share by Application (2026-2031) |
Table 37 | :Global Famciclovir Revenue by Application 2020 VS 2024 VS 2031 (W Units) |
Table 38 | :Global Famciclovir Revenue by Application (2020-2025) & (W Units) |
Table 39 | :Global Famciclovir Revenue by Application (2026-2031) & (W Units) |
Table 40 | :Global Famciclovir Revenue Market Share by Application (2020-2025) |
Table 41 | :Global Famciclovir Revenue Market Share by Application (2026-2031) |
Table 42 | :Global Famciclovir Sales by Region: 2020 VS 2024 VS 2031 (W Units) |
Table 43 | :Global Famciclovir Sales by Region (2020-2025) & (W Units) |
Table 44 | :Global Famciclovir Sales Market Share by Region (2020-2025) |
Table 45 | :Global Famciclovir Sales Forecasted by Region (2026-2031) & (W Units) |
Table 46 | :Global Famciclovir Sales Forecasted Market Share by Region (2026-2031) |
Table 47 | :North America Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units) |
Table 48 | :North America Famciclovir Sales by Country (2020-2025) & (W Units) |
Table 49 | :North America Famciclovir Sales by Country (2026-2031) & (W Units) |
Table 50 | :Europe Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units) |
Table 51 | :Europe Famciclovir Sales by Country (2020-2025) & (W Units) |
Table 52 | :Europe Famciclovir Sales by Country (2026-2031) & (W Units) |
Table 53 | :Asia Pacific Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units) |
Table 54 | :Asia Pacific Famciclovir Sales by Country (2020-2025) & (W Units) |
Table 55 | :Asia Pacific Famciclovir Sales by Country (2026-2031) & (W Units) |
Table 56 | :South America, Middle East and Africa Famciclovir Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (W Units) |
Table 57 | :South America, Middle East and Africa Famciclovir Sales by Country (2020-2025) & (W Units) |
Table 58 | :South America, Middle East and Africa Famciclovir Sales by Country (2026-2031) & (W Units) |
Table 59 | :Global Famciclovir Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Table 60 | :Global Famciclovir Revenue by Region (2020-2025) & (US$ Million) |
Table 61 | :Global Famciclovir Revenue by Region (2026-2031) & (US$ Million) |
Table 62 | :Global Famciclovir Revenue Market Share by Region (2020-2025) |
Table 63 | :Global Famciclovir Revenue Market Share by Region (2026-2031) |
Table 64 | :Teva Company Information |
Table 65 | :Teva Business Overview |
Table 66 | :Teva Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 67 | :Teva Famciclovir Product Portfolio |
Table 68 | :Teva Recent Development |
Table 69 | :Shandong Luoxin Pharmaceutical Group Company Information |
Table 70 | :Shandong Luoxin Pharmaceutical Group Business Overview |
Table 71 | :Shandong Luoxin Pharmaceutical Group Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 72 | :Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio |
Table 73 | :Shandong Luoxin Pharmaceutical Group Recent Development |
Table 74 | :Novartis Company Information |
Table 75 | :Novartis Business Overview |
Table 76 | :Novartis Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 77 | :Novartis Famciclovir Product Portfolio |
Table 78 | :Novartis Recent Development |
Table 79 | :Mylan Company Information |
Table 80 | :Mylan Business Overview |
Table 81 | :Mylan Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 82 | :Mylan Famciclovir Product Portfolio |
Table 83 | :Mylan Recent Development |
Table 84 | :Hainan choitec Pharmaceuticals Company Information |
Table 85 | :Hainan choitec Pharmaceuticals Business Overview |
Table 86 | :Hainan choitec Pharmaceuticals Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 87 | :Hainan choitec Pharmaceuticals Famciclovir Product Portfolio |
Table 88 | :Hainan choitec Pharmaceuticals Recent Development |
Table 89 | :Chengdu Diao Pharmaceutical Group Company Information |
Table 90 | :Chengdu Diao Pharmaceutical Group Business Overview |
Table 91 | :Chengdu Diao Pharmaceutical Group Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 92 | :Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio |
Table 93 | :Chengdu Diao Pharmaceutical Group Recent Development |
Table 94 | :Beijing Jialin Pharmaceutical Company Information |
Table 95 | :Beijing Jialin Pharmaceutical Business Overview |
Table 96 | :Beijing Jialin Pharmaceutical Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 97 | :Beijing Jialin Pharmaceutical Famciclovir Product Portfolio |
Table 98 | :Beijing Jialin Pharmaceutical Recent Development |
Table 99 | :Macleods Pharmaceuticals Company Information |
Table 100 | :Macleods Pharmaceuticals Business Overview |
Table 101 | :Macleods Pharmaceuticals Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 102 | :Macleods Pharmaceuticals Famciclovir Product Portfolio |
Table 103 | :Macleods Pharmaceuticals Recent Development |
Table 104 | :HISUN Company Information |
Table 105 | :HISUN Business Overview |
Table 106 | :HISUN Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 107 | :HISUN Famciclovir Product Portfolio |
Table 108 | :HISUN Recent Development |
Table 109 | :Hikma Company Information |
Table 110 | :Hikma Business Overview |
Table 111 | :Hikma Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 112 | :Hikma Famciclovir Product Portfolio |
Table 113 | :Hikma Recent Development |
Table 114 | :HETERO Company Information |
Table 115 | :HETERO Business Overview |
Table 116 | :HETERO Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 117 | :HETERO Famciclovir Product Portfolio |
Table 118 | :HETERO Recent Development |
Table 119 | :Cipla Company Information |
Table 120 | :Cipla Business Overview |
Table 121 | :Cipla Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 122 | :Cipla Famciclovir Product Portfolio |
Table 123 | :Cipla Recent Development |
Table 124 | :Aurobindo Pharma Company Information |
Table 125 | :Aurobindo Pharma Business Overview |
Table 126 | :Aurobindo Pharma Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 127 | :Aurobindo Pharma Famciclovir Product Portfolio |
Table 128 | :Aurobindo Pharma Recent Development |
Table 129 | :Apotex Company Information |
Table 130 | :Apotex Business Overview |
Table 131 | :Apotex Famciclovir Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025) |
Table 132 | :Apotex Famciclovir Product Portfolio |
Table 133 | :Apotex Recent Development |
Table 134 | :Key Raw Materials |
Table 135 | :Raw Materials Key Suppliers |
Table 136 | :Famciclovir Distributors List |
Table 137 | :Famciclovir Customers List |
Table 138 | :Research Programs/Design for This Report |
Table 139 | :Authors List of This Report |
Table 140 | :Secondary Sources |
Table 141 | :Primary Sources |
List of Figures
Figure 1 | :Famciclovir Product Image |
Figure 2 | :Global Famciclovir Market Size (US$ Million), 2020 VS 2024 VS 2031 |
Figure 3 | :Global Famciclovir Market Size (2020-2031) & (US$ Million) |
Figure 4 | :Global Famciclovir Sales (2020-2031) & (W Units) |
Figure 5 | :Global Famciclovir Average Price (US$/Unit) & (2020-2031) |
Figure 6 | :Global Top 5 and 10 Famciclovir Players Market Share by Revenue in 2023 |
Figure 7 | :Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023 |
Figure 8 | :125 mg Tablets Image |
Figure 9 | :250 mg Tablets Image |
Figure 10 | :500 mg Tablets Image |
Figure 11 | :Global Famciclovir Sales by Type (2020 VS 2024 VS 2031) & (W Units) |
Figure 12 | :Global Famciclovir Sales Market Share 2020 VS 2024 VS 2031 |
Figure 13 | :Global Famciclovir Sales Market Share by Type (2020-2031) |
Figure 14 | :Global Famciclovir Revenue by Type (2020 VS 2024 VS 2031) & (W Units) |
Figure 15 | :Global Famciclovir Revenue Market Share 2020 VS 2024 VS 2031 |
Figure 16 | :Global Famciclovir Revenue Market Share by Type (2020-2031) |
Figure 17 | :Cold Sores Image |
Figure 18 | :Shingles Image |
Figure 19 | :Genital Herpes Image |
Figure 20 | :Global Famciclovir Sales by Application (2020 VS 2024 VS 2031) & (W Units) |
Figure 21 | :Global Famciclovir Sales Market Share 2020 VS 2024 VS 2031 |
Figure 22 | :Global Famciclovir Sales Market Share by Application (2020-2031) |
Figure 23 | :Global Famciclovir Revenue by Application (2020 VS 2024 VS 2031) & (W Units) |
Figure 24 | :Global Famciclovir Revenue Market Share 2020 VS 2024 VS 2031 |
Figure 25 | :Global Famciclovir Revenue Market Share by Application (2020-2031) |
Figure 26 | :North America Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 27 | :North America Famciclovir Sales Market Share by Country (2020-2031) |
Figure 28 | :U.S. Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 29 | :Canada Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 30 | :Mexico Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 31 | :Europe Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 32 | :Europe Famciclovir Sales Market Share by Country (2020-2031) |
Figure 33 | :Germany Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 34 | :France Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 35 | :U.K. Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 36 | :Italy Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 37 | :Netherlands Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 38 | :Asia Pacific Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 39 | :Asia Pacific Famciclovir Sales Market Share by Country (2020-2031) |
Figure 40 | :China Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 41 | :Japan Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 42 | :South Korea Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 43 | :Southeast Asia Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 44 | :India Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 45 | :Australia Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 46 | :South America, Middle East and Africa Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 47 | :South America, Middle East and Africa Famciclovir Sales Market Share by Country (2020-2031) |
Figure 48 | :Brazil Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 49 | :South Africa Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 50 | :Saudi Arabia Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 51 | :Turkey Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 52 | :Argentina Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 53 | :UAE Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 54 | :Egypt Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 55 | :Chile Famciclovir Sales and Growth Rate (2020-2031) & (W Units) |
Figure 56 | :Global Famciclovir Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million) |
Figure 57 | :Global Famciclovir Revenue Market Share by Region in Percentage: 2023 Versus 2030 |
Figure 58 | :North America Famciclovir Revenue (2020-2031) & (US$ Million) |
Figure 59 | :North America Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031 |
Figure 60 | :Europe Famciclovir Revenue (2020-2031) & (US$ Million) |
Figure 61 | :Europe Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031 |
Figure 62 | :Asia-Pacific Famciclovir Revenue (2020-2031) & (US$ Million) |
Figure 63 | :Asia-Pacific Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031 |
Figure 64 | :South America, Middle East and Africa Famciclovir Revenue (2020-2031) & (US$ Million) |
Figure 65 | :South America, Middle East and Africa Famciclovir Revenue Share by Country: 2020 VS 2024 VS 2031 |
Figure 66 | :Famciclovir Value Chain |
Figure 67 | :Manufacturing Cost Structure |
Figure 68 | :Famciclovir Production Mode & Process |
Figure 69 | :Direct Comparison with Distribution Share |
Figure 70 | :Distributors Profiles |
Figure 71 | :Years Considered |
Figure 72 | :Research Process |
Figure 73 | :Key Executives Interviewed |
Request a Sample
Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Pharma & Healthcare
Global Famciclovir Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Pages: 199
Complete Your Request
Customer reviews
- 0 out of 5
- 0 Reviews
5
4
3
2
1
No Rating Review Exist.
Write Review
Suggested Report
View MoreNo data found.